◀ Back to CD79A

CBL — CD79A

Pathways - manually collected, often from reviews:

• Reactome Reaction: CD79A → CBL (indirect_complex) Watanabe et al., Biochem Biophys Res Commun 2000, Engels et al., Eur J Immunol 2001, Kabak et al., Mol Cell Biol 2002, Chiu et al., EMBO J 2002, Oellerich et al., Mol Cell Proteomics 2009, Oellerich et al., EMBO J 2011, Fu et al., J Biol Chem 1997, Fu et al., Immunity 1998, Wienands et al., J Exp Med 1998
• Reactome Reaction: CD79A → CBL (reaction) Watanabe et al., Biochem Biophys Res Commun 2000, Engels et al., Eur J Immunol 2001, Kabak et al., Mol Cell Biol 2002, Chiu et al., EMBO J 2002, Oellerich et al., Mol Cell Proteomics 2009, Oellerich et al., EMBO J 2011, Fu et al., J Biol Chem 1997, Fu et al., Immunity 1998, Wienands et al., J Exp Med 1998

Text-mined interactions from Literome

Yankee et al., J Immunol 1999 : These studies indicate that c-Cbl may contribute to the regulation of BCR signaling by modulating the ability of Syk to associate with the BCR and couple the receptor to intracellular signaling pathways
Dragone et al., Proc Natl Acad Sci U S A 2006 : Coexpression of SLAP and c-Cbl in Bal-17 led to decreased surface and total BCR levels
Mao et al., Proc Natl Acad Sci U S A 2010 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) : As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia
Kimata et al., Adv Neuroimmunol 1996 : In B cell lines, GM-1056, IM-9, and CBL , VIP enhanced IgA1 , IgG1 and IgM production, respectively, in a dose dependent fashion, while the other neuropeptides somatostatin (SOM) or substance P ( SP ) failed to do so